HIGGINS ARTHUR J 4

4 · ZIMMER BIOMET HOLDINGS, INC. · Filed Jun 2, 2025

Form 4

Period: 2025-05-29

Director

Transactions

Award
Phantom Stock Units
2025-05-29+810.46→ 34,904.384 total
Exercise: $92.54→ Common Stock (810.46 underlying)
Award
Restricted Stock Units
2025-05-29$5.00/sh+1,404.798$7,024→ 24,864.726 total
→ Common Stock (1,404.798 underlying)

Footnotes (6)

[F1]The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.
[F2]The Conversion or Exercise Price of Derivative Security is 1-for-1.
[F3]These units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
[F4]Includes 79.853 phantom stock units accrued on April 30, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
[F5]The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
[F6]Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Documents

1 file